Explore educational content from VCCC lectures, symposia and conferences to be informed of the latest developments.
Friday 19 February 2021
VCCC Breast Cancer Symposium with Dr Ann Partridge, Dana-Farber Cancer Institute and Harvard Medical School.
What are the improvements in therapy and care for young women with breast cancer, and how can we apply these in Australia?
Dr Partridge explores the complexities of breast cancer in young women. Due to its rarity, treatment is often based on data from trials conducted among older women. This means that many aspects of the disease in younger women are not well understood and may result in long-term effects of treatment, and specific survivorship issues such as infertility.
Monday 15 February 2021
Monday Lunch Live with Dr Megan Prictor, Melbourne Law School and Amelia Hyatt, Department of Cancer Experiences Research, Peter MacCallum Cancer Centre.
Listening to a recording of a consultation with their health provider can help patients remember and understand what was discussed while giving them the opportunity to share information about a diagnosis or treatment regime with family members. New technologies to facilitate consultation recording are being developed globally - including the SECOND Ears smartphone app. This presentation explores the legal questions the SECOND Ears app has raised, and the results of a comprehensive analysis of Australian law pertaining to consultation recording.
Monday 8 February 2021
Monday Lunch Live with Professor Nick Huntington, Head of the Cancer Immunotherapy Laboratory, Biomedicine Discovery Institute, Monash University.
Emerging leader in the field of cancer immunology, Professor Huntington discusses how NK cells offer a safe cancer immunotherapy target and discuss therapeutic strategies to harness NK cell activity that is being developed at a rapid rate.
Thursday 4 February 2021
World Cancer Day with Dr Belinda Lee, Dr Stephen Luen and Dr Richard Tothill and consumer representative Vicky Morrison.
This special World Cancer Day event builds awareness of genetic testing and its impacts on cancer care. Our panel explores the opportunities that occur when patients, researchers and clinicians work together in a truly multidisciplinary way - and how this can progress cancer care universally.
Tuesday 1 December 2020
RACGP and VCCC event with presenters Professor Jon Emery, VCCC Primary Care Research and Education Lead, Professor Linda Mileshkin, Medical Oncologist and Deputy Director of Medical Oncology, Peter MacCallum Cancer Centre, Associate Professor Orla McNally Gynaecological Oncologist and Director of Oncology, Gynaecology, Royal Women’s Hospital.
Experts discuss the significant role General Practitioners play in gynaecological cancer prevention, screening, follow-up after treatment and palliative care and the scope to expand the role in collaboration with cancer specialists.
Monday 23 November 2020
Monday Lunch Live with presenter Associate Professor Lesley Stafford, Clinical Psychologist and Head of Clinical Psychology at The Royal Women’s Hospital and host Kirsten Pilatti, CEO, Breast Cancer Network Australia.
Professor Stafford discusses the mental health signs to watch for during and after a breast cancer diagnosis identifying when and how depression and anxiety can impact on day-to-day lives, and how to navigate the health system to find key professionals and support networks who can help.
Monday 30 November 2020
Monday Lunch Live with presenter Professor Christobel Saunders AO and Professor Nancy Baxter, Head of the Melbourne School of Population of Population and Global Health, The University of Melbourne.
Internationally recognised cancer expert Professor Christobel Saunders AO discusses the value-based system approach to service, delivery, payment, and policy to improve the lives of those diagnosed with cancer. She explains what value-based healthcare is, how to measure variability in outcomes and how to organise cancer care in a value-based model.
Monday 7 December 2020
Monday Lunch Live with Jon Yeo, Executive Coach, Board Member of Professional Speakers Australia and licensee of TEDx Melbourne.
Today, science communication has a real challenge to separate itself from noise and fake news. If real science is to make its mark, we need to understand modern communication practice that is clear, concise and builds trust. How does science need to be responsible and responsive to the community especially in the post-COVID-19 era?
In this interactive webinar, Jon works with participants to develop a short and effective narrative, and shares tips on creating memorable "sound bites" and moments, creating trust and rapport with your audience and cutting through 'fake-news'.
Monday 9 November 2020
Monday Lunch Live with presenter Professor Ben Solomon, Peter MacCallum Cancer Centre and A/Professor Gavin Wright
Lung cancers account for more cancer related deaths than any cancer worldwide. About 3 to 5% of patients with non-small cell lung cancer have tumours with rearrangements in the anaplastic lymphoma kinase gene.
Professor Solomon discusses the phase I to III clinical trials that are dramatically improving outcomes for patients with advanced lung cancer.
Thursday 5 November 2020
RACGP and VCCC event with presenter Professor Jon Emery, VCCC Primary Care Research and Education Lead.
An expert panel share commonplace experiences in the head and neck cancer pathway - from diagnosis, presenting symptoms to management principles and follow-up care with tips on best practice care, key communication points and challenges GPs face.
Wednesday 4 November 2020
Grand Round Breast Cancer with presenter Dr Shom Goel, Clinician-Scientist, Peter MacCallum Cancer Centre.
CDK4/6 inhibitors are a new class of drugs that have revolutionised the treatment of breast cancer. In this webinar, Dr Shom Goel reviews the rationale behind the development of CDK4/6 inhibitors and discusses recent laboratory data suggesting that their effects in cancer are much more complicated than previously imagined.
Friday 6 November 2020
Cancer and COVID-19 in Victoria with presenter Dr Ziad Bakouny.
Globally, people with cancer are one of the largest groups to be impacted by COVID-19. In addition to the physical impact on patients, the delivery of cancer care and research has been severely disrupted.
Dr Ziad Bakouny, Dana-Farber Cancer Institute, Boston USA, highlights the biological interplay between the two diseases and provides practical recommendations for the treatment of patients with cancer during the pandemic.
Ziad Bakouny, MD, MSc is a post-doctoral research fellow at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute (DFCI).
Monday 26 October 2020
Monday Lunch Live with presenter Dr Jennifer McQuade, MD Anderson Cancer Centre
Immunotherapy has dramatically changed the landscape of cancer care, with numerous immunotherapeutic strategies now being implemented across the therapeutic continuum. However, despite this tremendous success, a significant proportion of patients still do not fully benefit from these therapies. Thankfully the microbiome—and the foods that feed it—is emerging as an important determinant of a patient’s response to immunotherapy, with promising outcomes.
Dr Jennifer McQuade, MD Anderson Cancer Centre reviews the gut microbiome and explains how it is an important emerging biomarker to be considered in the response to revolutionary new cancer therapies.
Wednesday 21 October 2020
Cancer and COVID-19 with presenter Professor Jon Emery, VCCC Primary Care Research and Education Lead.
COVID-19 restrictions in Victoria has led to a reduction in pathology notifications for cancer of approximately 30 per cent for the five most common cancers. These cancers represent 60 per cent of all cancer diagnoses. This webinar aims to provide support and advice to clinicians and health care services treating patients with cancer during the COVID-19 pandemic.
Leading experts discuss the role of primary care professionals in addressing community concerns during COVID-19, identifying and responding to patients presenting with a late diagnosis cancer and the consequences of delayed cancer diagnoses on the health system.
Monday 19 October 2020
Monday Lunch Live with presenters Professor Joe Trapani and Associate Professor Paul Neeson. Moderated by Professor Sharon Lewin AO.
In the past decade, adoptive immunotherapies in the form of recombinant checkpoint antibodies or chimeric antigen receptor CAR T-cells have realised a century-long quest to harness the immune system to control established cancer.
Professor Trapani, Head Cancer Immunology Program, Peter MacCallum Cancer Centre reflects on the history of CAR T-cell technology and explores strategies currently being developed to extend the range of cancers for which CAR T and related approaches can prove effective. Joined by Associate Professor Paul Neeson, Group Leader, Cancer Immunology Program and moderated by Professor Sharon Lewin AO, Director, The Peter Doherty Institute for Infection and Immunity.
Monday 12 October 2020
Monday Lunch Live with presenter Dr Orazio Vittorio
Blocking copper uptake in tumour cells may be a clue to boosting immune system - fighting the deadliest of cancers.
Dr Vittorio, Head of The Metal-Targeted Therapy and Immunology Lab at the Children's Cancer Institute NSW has identified a strong connection between copper transporters found in malignant cancer tissue compared with normal tissue (copper transporter 1 CTR-1 and PD-L1). He presents cutting-edge research that proves that chelation therapy enhances anti-tumour immune responses and could be repurposed for immune checkpoint inhibition.
Friday 9 October 2020
Cancer and COVID-19 in Victoria with Professor Jennifer Philip, Danielle Spence, Associate Professor Brian Le, Associate Professor Mark Boughey, Dr Michelle Gold, Gael Wilder and Dan Fleming
For people requiring care due to a life-limiting illness, and the healthcare workers who care for them, COVID-19 presents particularly complex physical, emotional and ethical challenges.
In this webinar a multidisciplinary panel explores the clinical, ethical and patient experience including challenges to service delivery, bridging the ethical priorities and compassionate care and the impact on patients and families.
Monday 5 October 2020
Monday Lunch Live with presenter Associate Professor Misty Jenkins
In this webinar Misty discusses her research into how CAR T-cell immunotherapy is providing an exciting new approach to enhance brain cancer survival rates.
The presentation covers the generation and testing of two novel chimeric antigen receptor T cells. The first targets EGFRvIII, which serves as an attractive therapeutic target for glioblastoma given its exquisitely tumour specific expression.
Monday 29 September 2020
Monday Lunch Live with Associate Professor Fiona Simpson
Associate Professor Fiona Simpson is a Fellow of the Queensland Head and Neck Cancer Centre. Her lab focuses on the translation of research findings into new cancer therapies and have recently generated an exciting new method for antibody-mediated cancer therapy. This breakthrough method reduces tumour target variation, reversing drug resistance and increasing drug targeting to tumour cells.
Hosted by Professor Mark Rosenthal, Peter MacCallum Cancer Centre, Fiona discusses findings of her labs recently completed Phase IB safety trials.
Thursday 3 September 2020
Clinical application of genomics with chair Ben Markman and various presenters.
Genomic literacy is increasingly important for oncologists.
This symposium provides insights into the clinical implementation of assays and how it can improve treatments. Genomics-based assays are increasingly used to guide clinical decision-making to select the most appropriate targeted therapy for patients. Listen to experts who share their knowledge on basic science and genetics, how to implement assays and the importance of patient consent. Molecular pathology reports are also dissected and explained.
Friday 11 September 2020
Cancer and Covid-19 in Victoria. Professor Eva Segelov, Director of Oncology, Monash Health, moderates a consumer and expert panel discussion about clinical trials during COVID-19.
Clinical trials are a critical element of progressive, evidence based cancer research and can provide access to cutting edge treatments for patients. This educational forum explores the challenges and opportunities that metropolitan and regional trial participants are facing during the COVID-19 pandemic, and the measures and innovations that have helped to keep trials running through this period.
Monday 7 September 2020
Monday Lunch Live with presenter Professor Dean Lusher.
Social network analysis (SNA) is a way of examining social connections allowing us to understand their patterns and implications. Social network analysis provides a framework for understanding social connectivity, and it is much more than just a method of analysis. It requires theory – an understanding of the reasons why we connect – to understand the structures of networks.
Professor Dean Lusher, Head of the Social Network Research Laboratory, Swinburne University, introduces Social Network Analysis (SNA) methods and explains how deeper understanding of social networks can be leveraged to benefit your work.
Monday 31 August 2020
Monday Lunch Live with Dr Simon Chu, Research Group Head of the Hormone Cancer Therapeutics Laboratory at the Hudson Institute of Medical Research in Melbourne
Dr Chu is an expert in ovarian granulosa cell tumours (GCT), a unique subset of deadly ovarian tumours.
His studies are focused on understanding the molecular mechanisms which contribute to the pathogenesis of GCT and may present novel therapeutic targets.
Dr Chu's presentation outlines what is known about this disease, the difficulty in treating it and how research aims to dissect the mechanisms which contribute to the development of GCT.
Friday 28 August 2020
Cancer and COVID-19 in Victoria. Professor Clare Delany, Clinical Ethicist at the Royal Children’s Hospital and Peter MacCallum Cancer Centre leads a thought-provoking panel discussion on the complexities of care and clinical ethics during COVID-19.
From the temporary pause of some cancer screening and research, to the restriction of visitors in hospitals, the COVID-19 global pandemic has profoundly affected the way cancer care is delivered, researched and experienced.
Drawing from real case examples, this informative webinar presents a range of ethical challenges encountered by cancer clinicians during the COVID-19 pandemic.
Monday 3 August 2020
Monday Lunch Live with Professor Gail Garvey
In this much anticipated presentation for 2020, Professor Garvey outlines research and key considerations to support the delivery and optimal care for Aboriginal and Torres Strait Islander people living with cancer.
A growing body of research has reported the significant disparities in cancer outcomes between Indigenous and non-Indigenous Australians, in part a result of factors relating to the accessibility, acceptability and effectiveness of health services. Although there is increasing awareness of these disparities, targeted culturally appropriate strategies to address these have been slow. Relatively little attention has been directed towards identifying and focusing on the psychosocial aspects of cancer for Indigenous patients, a critical component in improving cancer care and outcomes.